- Participants in our Network
- Gender studies
- Education and Teaching
- Updates, Event Notices, Schedules
-
Archive
- Drug screening on tumor organoids exposes therapeutic vulnerabilities of meningiomas to HDAC1/2i panobinostat
- Multidisciplinary management of meningiomas in the era of precision oncology
- Spatial single cell transcriptomic analysis informs tumor developmental hierarchy of DICER1 syndrome related sarcoma
- From Anatomy to Outcome: Linking Glioma Location Patterns to Survival Using Non-Negative Matrix Factorization
- Prognostic impact of radiotherapy timing in WHO grade 2 and 3 meningiomas utilizing an integrated molecular-morphologic classification
- Profiling of rare immune cell populations and integrative analysis identify immune ecotypes in newly diagnosed meningiomas
- The HIT Network for Children and Adolescents With CNS Tumors Facilitates Improvements of Diagnostic Assessments, Multimodal Treatments, Individual Counseling, and Research in Germany, Austria, and Switzerland
- Prognostic relevance of resection at first recurrence in isocitrate dehydrogenase mutant lower-grade glioma: results from a retrospective, single-center, volumetric analysis
- Artificial intelligence pipeline predicts the integrated molecular-morphologic risk score of meningiomas from routine preoperative MRI
- Spatial Transcriptomics Characterisation of Radionecrotic Changes in Glioblastoma Patients
- A comparative analysis of CD70-directed CAR-T cells for glioblastoma treatment demonstrates a superior efficacy of the ligand-based construct
- MGMT promoter methylation modulates the effect of residual tumor on survival after re-resection of recurrent glioblastoma
- The prognostic impact of CDKN2A/B hemizygous deletions in meningioma
- A microenvironment-determined risk continuum refines subtyping in meningioma and reveals determinants of machine learning-based tumor classification
- GREB1-rearranged uterine tumour shares a common DNA methylation signature with ESR1-rearranged UTROSCT
- Molecular and Clinical Stratification of Astroblastomas: Three distinct Fusion-Defined Groups Informing Risk-Adapted Treatment Strategies
- PTEN deficiency linked to chromosome 10q loss leads to aggressive NF2 mutant meningioma biology
- IDH-mutant gliomas arise from glial progenitor cells harboring the initial driver mutation
- Early distant progression in adult Histone-3 K27-altered diffuse midline gliomas
- Primary Cutaneous SWI/SNF-Deficient Carcinomas: Morphologic, Immunohistochemical, and Molecular Analysis of Seven Cases
Education and Teaching
The Gender & Queer Studies Certificate of Advanced Studies (CAS) offers an interdisciplinary, research-oriented, and practice-focused additional qualification for master's students and doctoral candidates from all academic fields. It provides theoretical and methodological foundations in Gender & Queer Studies, promotes the analysis of discrimination mechanisms, and supports the development of an individual academic or professional profile. The program aims to enable participants to engage critically and reflexively with gender-related issues and to help shape gender-equitable discourses and practices in both academia and professional contexts.
- Participants in our Network
- Gender studies
- Education and Teaching
- Updates, Event Notices, Schedules
-
Archive
- Drug screening on tumor organoids exposes therapeutic vulnerabilities of meningiomas to HDAC1/2i panobinostat
- Multidisciplinary management of meningiomas in the era of precision oncology
- Spatial single cell transcriptomic analysis informs tumor developmental hierarchy of DICER1 syndrome related sarcoma
- From Anatomy to Outcome: Linking Glioma Location Patterns to Survival Using Non-Negative Matrix Factorization
- Prognostic impact of radiotherapy timing in WHO grade 2 and 3 meningiomas utilizing an integrated molecular-morphologic classification
- Profiling of rare immune cell populations and integrative analysis identify immune ecotypes in newly diagnosed meningiomas
- The HIT Network for Children and Adolescents With CNS Tumors Facilitates Improvements of Diagnostic Assessments, Multimodal Treatments, Individual Counseling, and Research in Germany, Austria, and Switzerland
- Prognostic relevance of resection at first recurrence in isocitrate dehydrogenase mutant lower-grade glioma: results from a retrospective, single-center, volumetric analysis
- Artificial intelligence pipeline predicts the integrated molecular-morphologic risk score of meningiomas from routine preoperative MRI
- Spatial Transcriptomics Characterisation of Radionecrotic Changes in Glioblastoma Patients
- A comparative analysis of CD70-directed CAR-T cells for glioblastoma treatment demonstrates a superior efficacy of the ligand-based construct
- MGMT promoter methylation modulates the effect of residual tumor on survival after re-resection of recurrent glioblastoma
- The prognostic impact of CDKN2A/B hemizygous deletions in meningioma
- A microenvironment-determined risk continuum refines subtyping in meningioma and reveals determinants of machine learning-based tumor classification
- GREB1-rearranged uterine tumour shares a common DNA methylation signature with ESR1-rearranged UTROSCT
- Molecular and Clinical Stratification of Astroblastomas: Three distinct Fusion-Defined Groups Informing Risk-Adapted Treatment Strategies
- PTEN deficiency linked to chromosome 10q loss leads to aggressive NF2 mutant meningioma biology
- IDH-mutant gliomas arise from glial progenitor cells harboring the initial driver mutation
- Early distant progression in adult Histone-3 K27-altered diffuse midline gliomas
- Primary Cutaneous SWI/SNF-Deficient Carcinomas: Morphologic, Immunohistochemical, and Molecular Analysis of Seven Cases